In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!

COP28 explained: A closer look at COP28's climate change solutions

By Aniket Gupta | 27 Dec 2023

The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.

What is a Ponzi scheme?

By Aniket Gupta | 06 Dec 2023

Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.

The Rise and Rise of HDFC Bank

03 Jul 2023

HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp

India’s Millet Revolution To Enrich Global Food Basket

02 Apr 2023

Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent 

Market predator Hindenburg preys on Adani stock

06 Mar 2023

Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation

Dr Reddy's Laboratories

Dr Reddy's announces settlement of Exelon (rivastigmine tartrate ) ANDA litigation with Novartis

By Our Corporate Bureau | 21 Jan 2008

Dr Reddy's gets US FDA nod for marketing Ciprofloxacin

By Our Corporate Bureau | 17 Nov 2007

Dr Reddy's and Rheoscience commence Phase III diabetes drug trials

By Our Corporate Bureau | 02 Aug 2007

Dr Reddy's commences operations in Nigeria

By Our Corporate Bureau | 16 Jun 2007

Dr Reddy's is setting up two SEZs

By Our Corporate Bureau | 19 May 2007

Dr Reddy's to join the race for Merck's generic business

By Our Corporate Bureau | 05 Feb 2007

Dr Reddy's to raise Rs 1,027 crore through additional ADS issue

By Our Corporate Bureau | 30 Nov 2006

Torrent in pact with DRL to market Listril and Listril Plus in Russia

By | 29 Nov 2006

US Court''s Zocor verdict to benefit Ranbaxy and Dr Reddy''s

By Rex Mathew | 15 Nov 2006

Dr Reddy's plans $235 million ADR issue

By Our Corporate Bureau | 14 Nov 2006

Dr Reddy's to get generic rights as Glaxo settles Imitrex patent row

By Our Corporate Bureau | 10 Oct 2006

Dr Reddy’s, ClinTec International announce co-development of anti-cancer compound

By Our Corporate Bureau | 28 Sep 2006

Dr Reddy's opens manufacturing facility at Visakhapatnam

By Our Corporate Bureau | 26 Sep 2006

Dr Reddy's acquires Spain's Litaphar: CNBC

By Our Corporate Bureau | 18 Sep 2006

Dr Reddy's Q4 losses rise 60 per cent

By Our Corporate Bureau | 01 Jun 2006

Dr Reddy's launches oral bronchodilator for asthma, COPD

By Our Corporate Bureau | 16 May 2006

Dr Reddy's receives US FDA approval for fexofenadine hydrochloride

By Our Corporate Bureau | 13 Apr 2006

Dr Reddy's in discussions with Sanofi-Aventis to settle Plavix litigation

By Our Corporate Bureau | 22 Mar 2006

Dr Reddy's beats Ranbaxy; snaps up Betapharm for €480 million

By Our Corporate Bureau | 16 Feb 2006

Dr Reddy's, Ranbaxy lead race to acquire 3i's stake in Betapharm

By Our Corporate Bureau | 03 Feb 2006

Merck allows Dr Reddy's to sell authorised generics of blockbuster drugs

By Our Corporate Bureau | 02 Feb 2006